Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Opioid Prescriber Education Mandate Could Be Added To User Fee Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

Sen. Rockefeller introduces amendment that would require 16 hours of training every three years to maintain DEA registration.

You may also be interested in...



Opioid Physician Training Options Remain Limited After Initial Launch

FDA encourages physicians to take advantage of an educational program funded by sponsors of the analgesics as part of the REMS for extended-release opioid products, but only three programs were identified by the March 1 launch date, with Boston University taking the lead.

Mandatory Training For Opioid Prescribers Remains Stuck On Drawing Board

FDA and DEA continued to negotiate through the Office of National Drug Control Policy on a viable option for a mandatory prescriber education program, which would be a large burden for whichever agency gets the job.

Opioid REMS Requires Sponsors To Launch Prescriber Training CME Within 9 Months

By the third year of continuing medical education efforts, FDA expects 60% of those who wrote a prescription for a long-acting/extended-release opioid in 2011 to receive training.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS074155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel